Published in J Hum Reprod Sci on October 01, 2013
Prevention of Ovarian Hyperstimulation Syndrome: A Review. Obstet Gynecol Int (2015) 0.78
Comparison of GnRH agonist, GnRH antagonist, and GnRH antagonist mild protocol of controlled ovarian hyperstimulation in good prognosis patients. Int J Endocrinol (2015) 0.77
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet (2007) 3.36
Why do couples discontinue in vitro fertilization treatment? A cohort study. Fertil Steril (2004) 2.70
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab (2003) 2.26
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod (2007) 2.11
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev (2011) 2.03
Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest (1998) 2.00
Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril (2001) 1.97
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev (2011) 1.83
The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev (2006) 1.75
High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril (1996) 1.75
Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod (1995) 1.74
Treatment-related chromosome abnormalities in human embryos. Hum Reprod (1997) 1.65
Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev (2006) 1.60
Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online (2006) 1.56
Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online (2006) 1.53
Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab (2004) 1.37
Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science (1981) 1.37
The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril (2005) 1.27
The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Hum Reprod Update (2008) 1.26
Ovarian stimulation and endometrial receptivity. Hum Reprod (1999) 1.24
A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril (2000) 1.18
The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod (2007) 1.15
Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab (2008) 1.13
Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects. Biol Reprod (2009) 1.12
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod (2009) 1.08
The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy. Hum Reprod (2007) 1.08
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol (2011) 1.08
Time to revolutionize ovarian stimulation. Hum Reprod (1996) 1.01
Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Hum Reprod (2007) 0.98
Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet (2008) 0.98
Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril (2010) 0.97
Is ovarian stimulation detrimental to the endometrium? Reprod Biomed Online (2007) 0.95
Chromosome 21 mosaic human preimplantation embryos predominantly arise from diploid conceptions. Fertil Steril (2005) 0.93
Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil Steril (2007) 0.86
Mild ovarian stimulation. J Assist Reprod Genet (2007) 0.86
Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Hum Reprod (2001) 0.86
Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study. Gynecol Endocrinol (2006) 0.86
Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction. Hum Reprod (1995) 0.85
Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF. Hum Reprod (2007) 0.84
The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. Hum Reprod (2005) 0.83
Preliminary experience with a low-cost stimulation protocol that includes letrozole and human menopausal gonadotropins in normal responders for assisted reproductive technologies. Fertil Steril (2006) 0.77